Patent US4965252A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4965252A Expired / Lapsed US ⏱️ 0.0 years remaining

Cholesterol-lowering combination compositions of guar gum and niacin

Assignee: HAUSER - KUHRTS Inc
•
Filing: 1988-06-28
•
Granted: 1990-10-23
•
Expires: 2008-06-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An antihyperlipidemic pharmaceutical or dietary supplement composition for oral use consisting essentially of a combination of niacin and guar gum, and a method of lowering cholesterol levels with such oral pharmaceutical composition, or by the simultaneous oral administration of the active ingredients thereof, which eliminates the usual undesirable flushing and itching side effects of niacin while effectively lowering cholesterol levels, especially LDL cholesterol levels, is disclosed.

Inventors

  • 👤 Eric H. Kuhrts

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 15:05
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0087; A61K9/0095; A61K31/00; A61K31/70; A61K31/715; A61K33/00; A61K33/06; A61K33/10; A61K36/00; A61K36/18; A61K36/185; A61K36/48; A61K47/00; A61K47/06; A61K47/08; A61K47/12; A61P; A61P3/00; A61P3/06

Claims Analysis

Total Claims: 33
Claim 1
Independent Claim 28 words
An oral antihyperlipidemic composition of nicotinic acid, having a reduced flushing effect, comprising an effective antihyperlipidemic amount of nicotinic acid and an effective cutaneous-flushingreducing amount of guar gum.
Claim 2
Dependent Claim 28 words
An oral antihyperlipidemic composition of nicotinic acid, having a reduced flushing effect, comprising an effective antihyperlipidemic amount of nicotinic acid and an effective cutaneous-flushingreducing amount of guar gum.
Claim 3
Dependent Claim 17 words
A composition of claim 1 wherein the composition contains at least about 50 mg of nicotinic acid.
Claim 4
Dependent Claim 17 words
A composition of claim 1 wherein the amount of guar gum is at least about 250 mg.
Claim 5
Dependent Claim 22 words
A composition of claim 2 wherein the amount of guar gum is at least about 400 mg, in capsule or tablet form.
Claim 6
Dependent Claim 20 words
A composition of claim 2 wherein the amount of guar gum is at least about 400 mg, and an antacid.
Claim 7
Dependent Claim 11 words
A composition of claim 4 comprising also a physiologically-acceptable magnesium salt.
Claim 8
Dependent Claim 19 words
A composition of claim 4 comprising also an orally-ingestible non-toxic mineral salt capable of dissolution in the gastric fluids.
Claim 9
Dependent Claim 23 words
A composition of claim 7, wherein the mineral salt is selected from the group consisting of calcium carbonate, magnesium carbonate, and potassium carbonate.
Claim 10
Dependent Claim 42 words
A composition of claim 1, wherein the active ingredients are in granular form and comprising also a quantity of a food-grade acid in powder form which is effective in extending the time for gelation of the resulting mix upon addition of water.
Claim 11
Dependent Claim 25 words
A composition of claim 9, wherein the food-grade acid is selected from the group consisting of citric acid, ascorbic acid, tartaric acid, and malic acid.
Claim 12
Dependent Claim 21 words
A composition of claim 8 comprising about 400-500 mg guar gum about 80-100 mg nicotinic acid about 80-100 mg magnesium carbonate.
Claim 13
Independent Claim 49 words
A method of combating hyperlipidemia in a subject in need of the same using nicotinic acid, characterized by reduced flushing effect, consisting essentially of the step of simultaneously administering orally to the said subject an effective antihyperlipidemic amount of nicotinic acid and an effective cutaneous-flushing-reducing amount of guar gum.
Claim 14
Independent Claim 49 words
A method of combating hyperlipidemia in a subject in need of the same using nicotinic acid, characterized by reduced flushing effect, consisting essentially of the step of simultaneously administering orally to the said subject an effective antihyperlipidemic amount of nicotinic acid and an effective cutaneous-flushing-reducing amount of guar gum.
Claim 15
Dependent Claim 31 words
Method of claim 12 comprising the step of administering orally to the said subject both nicotinic acid and guar gum, in the form of a pharmaceutical composition containing both active ingredients.
Claim 16
Dependent Claim 17 words
Method of claim 13 wherein the active consisting essentially of ingredients are in capsule or tablet form.
Claim 17
Dependent Claim 15 words
Method of claim 14 wherein said method also comprises administration of a physiologically-acceptable mineral salt.
Claim 18
Dependent Claim 21 words
Method of claim 13, wherein a single dose comprises about 300-500 mg of niacin and about 1.5-2.5 g of guar gum.
Claim 19
Dependent Claim 28 words
Method of claim 15, wherein a single dose comprises about 300-500 mg niacin, about 1.5-2.5 g of guar gum, and about 300-500 mg of a physiologicallyacceptable magnesium salt.
Claim 20
Dependent Claim 23 words
Method of claim 12 wherein a dosage unit comprises at least about 250 mg guar gum and at least about 50 mg niacin.
Claim 21
Dependent Claim 24 words
Method of claim 16 wherein a single dose comprises at least about 2 g guar gum and at least about 350 mg of niacin.
Claim 22
Dependent Claim 30 words
Method of claim 15 wherein a daily dose comprises at least about 6 g guar gum, at least about 1 g niacin, and at least about 1 g magnesium carbonate.
Claim 23
Dependent Claim 21 words
Method of claim 12, wherein an orally-ingestible non-toxic mineral salt capable of dissolution in the gastric fluid is simultaneously orally administered.
Claim 24
Dependent Claim 15 words
Method of claim 21 wherein the non-toxic mineral salt is a physiologically acceptable magnesium salt.
Claim 25
Dependent Claim 12 words
Method of claim 22 wherein the physiologicallyacceptable magnesium salt is magnesium carbonate.
Claim 26
Dependent Claim 48 words
Method of claim 12, wherein the active ingredients are in granular form and wherein a quantity of a foodgrade acid also in powder form which is effective in extending the time for gelation of the resulting mix upon addition of water is also concurrently or simultaneously orally administered.
Claim 27
Dependent Claim 22 words
Method of claim 21, wherein the mineral salt is selected from the group consisting of calcium carbonate, magnesium carbonate, and potassium carbonate.
Claim 28
Dependent Claim 12 words
Method of claim 15, wherein the salt is a physiologically-acceptable magnesium salt.
Claim 29
Dependent Claim 27 words
Method of claim 24, wherein the food-grade acid is an organic acid selected from the group consisting of citric acid, ascorbic acid, tartaric acid, and malic acid.
Claim 30
Dependent Claim 22 words
A composition of claim 1, wherein the ratio of guar gum by weight to nicotinic acid by weight is at least 3:1.
Claim 31
Dependent Claim 21 words
Method of claim 12, wherein the ratio of guar gum by weight to nicotinic acid by weight is at least 3:1.
Claim 32
Dependent Claim 24 words
A composition of claim 28, wherein the ratio of guar gum by weight to nicotinic acid by weight is about 3:1 to about 8.3:1.
Claim 33
Dependent Claim 23 words
Method of claim 29, wherein the ratio of guar gum by weight to nicotinic acid by weight is about 3:1 to about 8.3:1.

References Cited (Backward Citations)

US3843778A Cited
US4237118A Cited
US4166902A Cited
US4764374A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-10-22 1994-04-23 1994-10-23 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-10-22 1998-04-23 1998-10-23 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-10-22 2002-04-23 2002-10-23 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag